Clinical Trial

Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-05
Trial Details
NCT Number NCT06433310
Lead Sponsor Weill Medical College of Cornell University
Conditions Gut Microbiome, Gut Health, Dietary Supplement, L-Phenylalanine, Phenylpropionic Acid
Enrollment 20 participants
Start Date 2024-10-17
Primary Completion 2027-12-17 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-26